294 related articles for article (PubMed ID: 33287301)
21. The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses.
Chalmers SA; Ayilam Ramachandran R; Garcia SJ; Der E; Herlitz L; Ampudia J; Chu D; Jordan N; Zhang T; Parodis I; Gunnarsson I; Ding H; Shen N; Petri M; Mok CC; Saxena R; Polu KR; Connelly S; Ng CT; Mohan C; Putterman C
J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34981775
[TBL] [Abstract][Full Text] [Related]
22. CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.
Oliveira MI; Gonçalves CM; Pinto M; Fabre S; Santos AM; Lee SF; Castro MA; Nunes RJ; Barbosa RR; Parnes JR; Yu C; Davis SJ; Moreira A; Bismuth G; Carmo AM
Eur J Immunol; 2012 Jan; 42(1):195-205. PubMed ID: 21956609
[TBL] [Abstract][Full Text] [Related]
23. Conserved Bacterial-Binding Peptides of the Scavenger-Like Human Lymphocyte Receptor CD6 Protect From Mouse Experimental Sepsis.
Martínez-Florensa M; Català C; Velasco-de Andrés M; Cañadas O; Fraile-Ágreda V; Casadó-Llombart S; Armiger-Borràs N; Consuegra-Fernández M; Casals C; Lozano F
Front Immunol; 2018; 9():627. PubMed ID: 29706953
[TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of CD6 on B-cell subsets from patients with Sjögren's syndrome.
Alonso R; Buors C; Le Dantec C; Hillion S; Pers JO; Saraux A; Montero E; Marianowski R; Loisel S; Devauchelle V; Youinou P; Renaudineau Y
J Autoimmun; 2010 Dec; 35(4):336-41. PubMed ID: 20810246
[TBL] [Abstract][Full Text] [Related]
25. Domain-specific CD6 monoclonal antibodies identify CD6 isoforms generated by alternative-splicing.
Santos RF; Oliveira L; Brown MH; Carmo AM
Immunology; 2019 Aug; 157(4):296-303. PubMed ID: 31162836
[TBL] [Abstract][Full Text] [Related]
26. Biochemical characterization of recombinant and circulating human Spalpha.
Sarrias MR; Padilla O; Monreal Y; Carrascal M; Abian J; Vives J; Yélamos J; Lozano F
Tissue Antigens; 2004 Apr; 63(4):335-44. PubMed ID: 15009805
[TBL] [Abstract][Full Text] [Related]
27. Gene Variation at Immunomodulatory and Cell Adhesion Molecules Loci Impacts Primary Sjögren's Syndrome.
Casadó-Llombart S; Gheitasi H; Ariño S; Consuegra-Fernández M; Armiger-Borràs N; Kostov B; Ramos-Casals M; Brito-Zerón P; Lozano F
Front Med (Lausanne); 2022; 9():822290. PubMed ID: 35372412
[TBL] [Abstract][Full Text] [Related]
28. Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR-B1.
Vasquez M; Simões I; Consuegra-Fernández M; Aranda F; Lozano F; Berraondo P
Eur J Immunol; 2017 Jul; 47(7):1108-1118. PubMed ID: 28504304
[TBL] [Abstract][Full Text] [Related]
29. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity.
Azzam HS; Grinberg A; Lui K; Shen H; Shores EW; Love PE
J Exp Med; 1998 Dec; 188(12):2301-11. PubMed ID: 9858516
[TBL] [Abstract][Full Text] [Related]
30. Genomic organization of the human CD5 gene.
Padilla O; Calvo J; Vilà JM; Arman M; Gimferrer I; Places L; Arias MT; Pujana MA; Vives J; Lozano F
Immunogenetics; 2000 Oct; 51(12):993-1001. PubMed ID: 11061284
[TBL] [Abstract][Full Text] [Related]
31. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
Burgess KE; Yamamoto M; Prasad KV; Rudd CE
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
[TBL] [Abstract][Full Text] [Related]
32. Identification of a mouse protein homologous to the human CD6 T cell surface protein and sequence of the corresponding cDNA.
Robinson WH; Prohaska SS; Santoro JC; Robinson HL; Parnes JR
J Immunol; 1995 Nov; 155(10):4739-48. PubMed ID: 7594475
[TBL] [Abstract][Full Text] [Related]
33. CD6-ligand interactions: a paradigm for SRCR domain function?
Aruffo A; Bowen MA; Patel DD; Haynes BF; Starling GC; Gebe JA; Bajorath J
Immunol Today; 1997 Oct; 18(10):498-504. PubMed ID: 9357143
[TBL] [Abstract][Full Text] [Related]
34. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5.
Bikah G; Lynd FM; Aruffo AA; Ledbetter JA; Bondada S
Int Immunol; 1998 Aug; 10(8):1185-96. PubMed ID: 9723705
[TBL] [Abstract][Full Text] [Related]
35. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
[TBL] [Abstract][Full Text] [Related]
36. The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation.
Osorio LM; Garcia CA; Jondal M; Chow SC
Cell Immunol; 1994 Mar; 154(1):123-33. PubMed ID: 7509726
[TBL] [Abstract][Full Text] [Related]
37. CD318 is a ligand for CD6.
Enyindah-Asonye G; Li Y; Ruth JH; Spassov DS; Hebron KE; Zijlstra A; Moasser MM; Wang B; Singer NG; Cui H; Ohara RA; Rasmussen SM; Fox DA; Lin F
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6912-E6921. PubMed ID: 28760953
[TBL] [Abstract][Full Text] [Related]
38. Recombinant CD5 and CD6 Ectodomains Induce Antiparasitic and Immunomodulatory Effects in Secondary Cystic Echinococcosis.
García-Luna J; Rivero-Osorio F; González-Porcile MC; Arbildi P; Miles S; Magnone J; Velasco-De-Andrés M; Dematteis S; Lozano F; Mourglia-Ettlin G
Parasite Immunol; 2024 Apr; 46(4):e13034. PubMed ID: 38625016
[TBL] [Abstract][Full Text] [Related]
39. Clinical and experimental evidence for targeting CD6 in immune-based disorders.
Consuegra-Fernández M; Lin F; Fox DA; Lozano F
Autoimmun Rev; 2018 May; 17(5):493-503. PubMed ID: 29526637
[TBL] [Abstract][Full Text] [Related]
40. Multifaceted effects of soluble human CD6 in experimental cancer models.
Simões IT; Aranda F; Casadó-Llombart S; Velasco-de Andrés M; Català C; Álvarez P; Consuegra-Fernández M; Orta-Mascaró M; Merino R; Merino J; Alberola-Ila J; González-Aseguinolaza G; Carreras E; Martínez V; Lozano F
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
